Suchergebnis | Hamburg Open Science

Facetten

47 Einträge gefunden

Enumeration and Changes in Circulating Tumor Cells and Their Prognostic Value in Patients Undergoing Cytoreductive Radical Prostatectomy for Oligometastatic Prostate Cancer-Translational Research Results from the Prospective ProMPT trial
2021 - Forschungsinformationssystem des UKE
A pre-specified model based on four kallikrein markers in blood improves predictions of adverse pathology and biochemical recurrence after radical prostatectomy
2020 - Forschungsinformationssystem des UKE
Tumor characteristics, oncological and functional outcomes after radical prostatectomy in very young men ≤ 45 years of age
2020 - Forschungsinformationssystem des UKE
High Chance of Late Recovery of Urinary and Erectile Function Beyond 12 Months After Radical Prostatectomy
2017 - Forschungsinformationssystem des UKE
Radical prostatectomy neutralizes obesity-driven risk of prostate cancer progression
2017 - Forschungsinformationssystem des UKE
External validation of the CAPRA-S score to predict biochemical recurrence, metastasis and mortality after radical prostatectomy in a European cohort
2015 - Forschungsinformationssystem des UKE
Open and robot-assisted radical retropubic prostatectomy in men receiving ongoing low-dose aspirin medication: revisiting an old paradigm?
2013 - Forschungsinformationssystem des UKE
The impact of the number of cores on tissue microarray studies investigating prostate cancer biomarkers.
2012 - Forschungsinformationssystem des UKE
Assessment of rates of lymph nodes and lymph node metastases in periprostatic fat pads in a consecutive cohort treated with retropubic radical prostatectomy
2012 - Forschungsinformationssystem des UKE
Full functional-length urethral sphincter preservation during radical prostatectomy.
2011 - Forschungsinformationssystem des UKE
High level PSMA expression is associated with early PSA recurrence in surgically treated prostate cancer.
2011 - Forschungsinformationssystem des UKE
Long-term data on the survival of patients with prostate cancer treated with radical prostatectomy in the prostate-specific antigen era.
2009 - Forschungsinformationssystem des UKE
Importance of baseline potency rate assessment of men diagnosed with clinically localized prostate cancer prior to radical prostatectomy.
2009 - Forschungsinformationssystem des UKE
Current Technique of Open Intrafascial Nerve-Sparing Retropubic Prostatectomy.
2009 - Forschungsinformationssystem des UKE
Percent free prostate-specific antigen (PSA) is an accurate predictor of prostate cancer risk in men with serum PSA 2.5 ng/mL and lower.
2008 - Forschungsinformationssystem des UKE
Validation of the contemporary epstein criteria for insignificant prostate cancer in European men.
2008 - Forschungsinformationssystem des UKE
Currently used criteria for active surveillance in men with low-risk prostate cancer: an analysis of pathologic features.
2008 - Forschungsinformationssystem des UKE
Assessment of pathological prostate cancer characteristics in men with favorable biopsy features on predominantly sextant biopsy.
2008 - Forschungsinformationssystem des UKE
Critical assessment of tools to predict clinically insignificant prostate cancer at radical prostatectomy in contemporary men.
2008 - Forschungsinformationssystem des UKE
[Technical aspects of nerve sparing during retropubic prostatectomy]
2007 - Forschungsinformationssystem des UKE

Aktive Facetten

Facetten

Zugriff

Einrichtung

Medientyp

Karte

Erscheinungsjahr

Autor/in

Sprache

Enumeration and Changes in Circulating Tumor Cells and Their Prognostic Value in Patients Undergoing Cytoreductive Radical Prostatectomy for Oligometastatic Prostate Cancer-Translational Research Results from the Prospective ProMPT trial

A pre-specified model based on four kallikrein markers in blood improves predictions of adverse pathology and biochemical recurrence after radical prostatectomy

Tumor characteristics, oncological and functional outcomes after radical prostatectomy in very young men ≤ 45 years of age

High Chance of Late Recovery of Urinary and Erectile Function Beyond 12 Months After Radical Prostatectomy

Radical prostatectomy neutralizes obesity-driven risk of prostate cancer progression

External validation of the CAPRA-S score to predict biochemical recurrence, metastasis and mortality after radical prostatectomy in a European cohort

Open and robot-assisted radical retropubic prostatectomy in men receiving ongoing low-dose aspirin medication: revisiting an old paradigm?

The impact of the number of cores on tissue microarray studies investigating prostate cancer biomarkers.

Assessment of rates of lymph nodes and lymph node metastases in periprostatic fat pads in a consecutive cohort treated with retropubic radical prostatectomy

Full functional-length urethral sphincter preservation during radical prostatectomy.

High level PSMA expression is associated with early PSA recurrence in surgically treated prostate cancer.

Long-term data on the survival of patients with prostate cancer treated with radical prostatectomy in the prostate-specific antigen era.

Importance of baseline potency rate assessment of men diagnosed with clinically localized prostate cancer prior to radical prostatectomy.

Current Technique of Open Intrafascial Nerve-Sparing Retropubic Prostatectomy.

Percent free prostate-specific antigen (PSA) is an accurate predictor of prostate cancer risk in men with serum PSA 2.5 ng/mL and lower.

Validation of the contemporary epstein criteria for insignificant prostate cancer in European men.

Currently used criteria for active surveillance in men with low-risk prostate cancer: an analysis of pathologic features.

Assessment of pathological prostate cancer characteristics in men with favorable biopsy features on predominantly sextant biopsy.

Critical assessment of tools to predict clinically insignificant prostate cancer at radical prostatectomy in contemporary men.

[Technical aspects of nerve sparing during retropubic prostatectomy]